Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Experimental Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis Bacteria July 19, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a groundbreaking experimental therapeutic DNA vaccine for tuberculosis (TB), delivered non-invasively through the nose.…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis July 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant TB Bacteria, Offering New Hope Against Global Health Scourge. July 5, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
